Regeneron Pharmaceuticals Inc. buy Truist Financial Co.
Start price
02.08.24
/
50%
€1,017.0
Target price
02.08.25
€1,101.5
Performance (%)
-52.59%
End price
03.08.25
€482.20
Summary
This prediction ended on 03.08.25 with a price of €482.20. The BUY prediction by Truist_Financial_Co_ for Regeneron Pharmaceuticals Inc. performed very badly with a performance of -52.59%. Truist_Financial_Co_ has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €1.72 are taken into consideration when calculating the performance. Truist_Financial_Co_ has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 2.606% | 2.606% | -53.657% |
| iShares Core DAX® | 0.648% | -0.148% | 32.392% |
| iShares Nasdaq 100 | -0.034% | 1.859% | 14.899% |
| iShares Nikkei 225® | 2.445% | 8.129% | 8.878% |
| iShares S&P 500 | 0.492% | 1.525% | 10.604% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $1,200.00 price target on the stock, up previously from $1,135.00.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€936.00
24.09.24
24.09.24
€1,075.4
24.09.25
24.09.25
-46.40%
12:28
12:28
Stopped prediction by Truist_Financial_Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€476.00
11.08.25
11.08.25
€696.13
11.08.26
11.08.26
5.04%
12:28
12:28
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€521.80
30.04.25
30.04.25
€826.73
30.04.26
30.04.26
-4.01%
12:28
12:28
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€522.60
23.04.25
23.04.25
€854.39
23.04.26
23.04.26
-4.16%
12:28
12:28
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€708.00
08.01.25
08.01.25
€973.98
08.01.26
08.01.26
-29.14%
12:28
12:28
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€782.60
01.11.24
01.11.24
€1,037.2
01.11.25
01.11.25
-35.89%
12:28
12:28
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€933.00
16.10.24
16.10.24
€1,045.5
16.10.25
16.10.25
-46.23%
12:28
12:28
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€885.20
03.04.24
03.04.24
€1,049.8
03.04.25
03.04.25
-38.43%
04.04.25
04.04.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€892.50
26.03.24
26.03.24
€1,046.4
26.03.25
26.03.25
-33.89%
27.03.25
27.03.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€779.00
18.12.23
18.12.23
€957.22
18.12.24
18.12.24
-11.96%
19.12.24
19.12.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€729.00
28.11.23
28.11.23
€951.37
28.11.24
28.11.24
-2.41%
29.11.24
29.11.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€734.00
16.08.23
16.08.23
€959.41
16.08.24
16.08.24
46.12%
17.08.24
17.08.24